Sort   by:  
 Page size 
ProteomicsHuman Uveal Melanome-surfaceome
A quantitative surface biotin-labeling approach combined with mass spectrometry was used to identify differentially expressed surface proteins in uveal melanoma (UM) cells, in which RAB1A was either knocked down or overexpressed, compared with the respective controls.
ORGANISM(S): Homo sapiens (Human) 
2026-09-14 | PXD069080 | Pride
Uveal melanome Surface proteome 
UnknownInfluence de la crise sanitaire COVID-19 sur un eventuel retard au diagnostic dans le melanome primitif
Not available
S-EPMC8603676 | biostudies-literature
UnknownDermatoscopic and clinical features of congenital or congenital-type nail matrix nevi: A multicenter prospective cohort study by the International Dermoscopy Society.
Not available
S-EPMC10035057 | biostudies-literature
TranscriptomicsTranscription profiling of mouse model of melanome secreting different amounts of histidine
We previously showed that transgenic enhancement of histamine production in B16-F10 melanomas strongly supports tumor growth in C57Bl/6 mice (Cancer Res, 2005 Pos et al.). In this array experiment, gene expression profiles of transgenic mouse melanomas, secreting different amounts of histamine, were...
ORGANISM(S): Mus musculus 
2008-06-16 | E-GEOD-8541 | biostudies-arrayexpress
ModelsKogan2013 - A mathematical model for the immunotherapeutic control of the TH1 TH2 imbalance in melanoma
This is a mathematical model describing the imbalance between T helper (Th1/Th2) cell types in melanome patients, together with its regulation via IL-12 treatment. The model focuses on the interactions between the two T helper cell types as mediated by their respective key cytokines, interferon gamm...
2024-09-02 | BIOMD0000000881 | BioModels
Immuno-oncology 
GenomicsConjunctival and mucosal melanoma
Conjunctival and mucosal melanoma
PRJNA602317 | ENA
ProteomicsUse of lymph-circulating extracellular vesicles as surrogate markers of melanoma progression and BRAFV600E mutation
Liquid biopsies are becoming imperative on early patient diagnosis, prognosis and evaluation of residual disease. The use of circulating extracellular vesicles (EVs) as surrogate markers of tumor progression could be a powerful tool in the clinical setting. EVs in plasma have emerged as a non-invasi...
ORGANISM(S): Homo sapiens (Human) 
2019-03-13 | PXD012042 | Pride
Extracellular vesicles Plasma Patients Serome Lc msms Melanome 
Sort   by:  
 Page size